January 2023 Issue Table Of Contents

From The Editor

• The Next Big Thing

Feature Articles

• Verve Therapeutics: How To Build a Gene Editing Biotech

CEO Corner

• What I Learned As CEO The First Time Around

Companies To Watch

• Ocelot Bio

Industry Research

• Phase 1 Study Complexity

Podcast Summary

• Anatomy Of A Biopharma VC Deal

Inside The Industry

• 3 Essentials For Choosing A Clinical Data Provider
• Avoid Trade Secret Lawsuits In The Life Science Talent War
• 6 Best Practices For Biopharma Talent Management In 2023
• Considering The Human Element Of Fraud
• Defining The RNA Therapeutics Industry In 2023
• Why Partnerships Fuel Innovation
• Peter Marks: Prioritizing Better Communication And Faster Product Reviews
• A New Funding Model For A New Approach To Pain

Industry Leader

• Why Founder CEOs Deliver In Bear Markets
• How IT Can Drive Life Sciences Innovation

Leadership Lessons

• To Advance Your Career, Cultivate Executive Presence

Ask The Board

• What Key Characteristics Or Attributes — Beyond Functional Or Scientific Expertise — Should A CEO Look For In Considering The Addition Of A New Board Member?
• What Advice Would You Give To Small Biotechs That Have Delayed Or Canceled Plans For A Public Offering, But Still Need Funding To Advance Clinical Programs?